Immunomodulation by MYB is associated with tumor relapse in patients with early stage colorectal cancer

Immunomodulation by MYB is associated with tumor relapse in patients with early stage colorectal cancer

The presence of tumor immune infiltrating cells (TILs), particularly CD8+ T-cells, is a robust predictor of outcome in patients with colorectal cancer (CRC). We revisited TIL abundance specifically in patients with microsatellite stable (MSS) CRC without evidence of lymph node or metastatic spread....

Full description

Bibliographic Details
Main Authors: Millen, R., Malaterre, J., Cross, R., Carpinteri, S., Desai, J., Tran, B., Darcy, P., Gibbs, P., Sieber, O., Zeps, Nikolajs, Waring, P., Fox, S., Pereira, L., Ramsay, R.
Format: Journal Article
Published: Landes Bioscience 2016
Online Access:http://hdl.handle.net/20.500.11937/19731

Internet

http://hdl.handle.net/20.500.11937/19731

Similar Items